Comparing Adriamycin vs Tecentriq
Adriamycin Remove Adriamycin from your drug comparison | Tecentriq Remove Tecentriq from your drug comparison |
---|
Adriamycin doxorubicin Remove Adriamycin from your drug comparison | Tecentriq atezolizumab Remove Tecentriq from your drug comparison | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescribed for Breast Cancer, Bladder Cancer, Acute Lymphoblastic Leukemia, Neuroblastoma, Thyroid Cancer, Stomach Cancer, Soft Tissue Sarcoma, Ovarian Cancer, Osteosarcoma, Lymphoma, Multiple... View more |
Prescribed for Bladder Cancer, Breast Cancer, Hepatocellular Carcinoma, Melanoma, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Urothelial Carcinoma. Tecentriq may also be used for purposes not... View more |
|
|||||||||||||||
Prescription only |
Prescription only |
||||||||||||||||
Ratings & ReviewsRecent helpful reviews |
|||||||||||||||||
6.6
For Breast Cancer: Adriamycin made me really weak and I had to have blood transfusions. I had 4 doses. I'm coming up on 3 years cancer free so I think it worked well. I'm concerned about the long term side effects. |
0.0
|
||||||||||||||||
Drug Class |
|||||||||||||||||
Side Effects |
|||||||||||||||||
Common side effects include: severe nausea and vomiting, nausea and vomiting, and alopecia. See the full Adriamycin side effects document. |
Common side effects include: herpes simplex encephalitis, infection, mycobacterium infection, retroperitoneal hemorrhage, sepsis, severe infection, urinary tract infection, colitis, diarrhea, and increased thyroid stimulating hormone level. See the full Tecentriq side effects document. |
||||||||||||||||
Pricing and Coupons* Prices are without insurance |
|||||||||||||||||
View all Adriamycin prices and generic prices |
View all Tecentriq prices |
||||||||||||||||
Generic Availability |
|||||||||||||||||
No |
|||||||||||||||||
Dosage Form(s) Available |
|||||||||||||||||
|
|
||||||||||||||||
Brand Names |
|||||||||||||||||
Other doxorubicin brands include: Adriamycin PFS, Adriamycin RDF |
N/A |
||||||||||||||||
Half LifeThe half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. |
|||||||||||||||||
30 hours |
648 hours |
||||||||||||||||
CSA Schedule**View glossary of terms. |
|||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category |
|||||||||||||||||
Category D
Positive evidence of risk
See the full Pregnancy Warnings document. |
Summary unavailable. See the full Pregnancy Warnings document. |
||||||||||||||||
FDA Alerts |
|||||||||||||||||
N/A |
|||||||||||||||||
Drug Interactions |
|||||||||||||||||
A total of 476 drugs are known to interact with Adriamycin:
|
A total of 109 drugs are known to interact with Tecentriq:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions |
|||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Disease Interactions |
|||||||||||||||||
First Approval Date |
|||||||||||||||||
N/A |
May 18, 2016 |
||||||||||||||||
WADA ClassView World Anti-Doping Agency classifications. |
|||||||||||||||||
N/A |
N/A |
||||||||||||||||
More Information |
|||||||||||||||||
Consumer Resources |
|||||||||||||||||
Professional Resources |
|||||||||||||||||
Related Treatment Guide |
|||||||||||||||||
|
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
For Breast Cancer: I did not experience any side effects, but based on a clinical trial result, I walked at a brisk pace for an hour most days to avoid cardiotoxicity.